VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Letrazuril
Phase 1
Small molecule
N
National Institute of Allergy and Infectious Diseases (NIAID)
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Diarrhea
1 trial
A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
Completed
·
N
National Institute of Allergy and Infectious Diseases (NIAID)
·
Phase 1
·
NCT00001018
·
32 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Letrazuril. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Letrazuril compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Letrazuril. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
National Institute of Allergy and Infectious Diseases (NIAID) company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
N
National Institute of Allergy and Infectious Diseases (NIAID)
Related News